Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):336–341. doi: 10.1097/QAI.0b013e3181b628be

Table 3. Description of Treatment History stratified by Gender.

All Women Men p-value

N 631 164 467
ARV naïve (%) 94.0 91.5 94.9 0.116
Year of regimen initiation (%) 0.581
 1995 –1998 45.6 45.1 45.8
 1999 –2001 27.9 25.6 28.7
 2002 – 2004 26.5 29.3 25.5
Type of ART regimen (%) 0.952
 NRTI-HAART 8.9 9.8 8.6
 PI-HAART 33.1 33.5 33.0
 NNRTI-HAART 33.8 32.3 34.3
 Other ART 24.3 24.4 24.2
Discontinued initial regimen(%) 78.1 78.1 78.2 0.977
Mean number of regimens/year (SD) 1.4 (±1.5) 1.5 (±1.5) 1.4 (±1.5) 0.444
Mean number of days off therapy/year (SD) 37.7 (±67.0) 49.0 (±73.8) 33.8 (±64.1) 0.020